Literature DB >> 116784

Membrane-bound antibodies to bloodstream Trypanosoma cruzi in mice: strain differences in susceptibility to complement-mediated lysis.

A U Krettli, P Weisz-Carrington, R S Nussenzweig.   

Abstract

The Y, CL and other strains of Trypanosoma cruzi display different morphological and immunological characteristics. Such observations are here extended to the interaction of bloodstream forms of different strains of T. cruzi with components of the complement system. We demonstrate that the bloodstream forms of the Y and B strains, but not those of the CL strain, are lysed by normal human serum. Lysis is mediated by combined activities of the alternative and classical complement pathways. These activities are triggered by antibodies on the surface of the parasites as shown by: (a) binding of fluorescein or radiolabelled anti-mouse immunoglobulin to the parasite's membrane and (b) the finding that bloodstream forms from lethally irradiated mice can be sensitized and rendered susceptible to complement-mediated lysis by incubation with sera from acutely infected animals. Bloodstream forms of the CL strain also bear surface immunoglobulin and sensitizing antibodies are present in the sera of mice infected with this strain. However, CL trypomastigotes from acutely infected mice fail to be lysed by human or mouse complement unless the parasites are pre-incubated with sera from chronically infected animals. The basis of the different interactions between CL and Y trypomastigotes with antibodies and the complement system, and their biological significance are discussed.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 116784      PMCID: PMC1537771     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi.

Authors:  Z BRENER
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1962 Nov-Dec       Impact factor: 1.846

2.  [Lytic effect of normal sera on cultured and sanguineous forms of Trypanosoma cruzi].

Authors:  M RUBIO
Journal:  Bol Chil Parasitol       Date:  1956 Oct-Dec

3.  The properdin system and immunity. I. Demonstration and isolation of a new serum protein, properdin, and its role in immune phenomena.

Authors:  L PILLEMER; L BLUM; I H LEPOW; O A ROSS; E W TODD; A C WARDLAW
Journal:  Science       Date:  1954-08-20       Impact factor: 47.728

4.  Presence of immunoglobulins on the surface of bloodstream Trypanosoma cruzi. Capping during differentiation in culture.

Authors:  J Kloetzel; M P Deane
Journal:  Rev Inst Med Trop Sao Paulo       Date:  1977 Nov-Dec       Impact factor: 1.846

Review 5.  Biology of Trypanosoma cruzi.

Authors:  Z Brener
Journal:  Annu Rev Microbiol       Date:  1973       Impact factor: 15.500

6.  The behavior of slender and stout forms of Trypanosoma cruzi in the blood-stream of normal and immune mice.

Authors:  Z Brener
Journal:  Ann Trop Med Parasitol       Date:  1969-06

7.  The in vitro interaction of Trypanosoma cruzi bloodstream forms and mouse peritoneal macrophages.

Authors:  A Alcantara; Z Brener
Journal:  Acta Trop       Date:  1978-09       Impact factor: 3.112

8.  Exacerbation of experimental Trypanosoma cruzi infection in mice by concomitant malaria.

Authors:  A U Krettli
Journal:  J Protozool       Date:  1977-11

9.  Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi.

Authors:  D B Budzko; M C Pizzimenti; F Kierszenbaum
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

10.  Antigenic modulation of Friend virus erythroleukemic cells in vitro by serum from mice with dormant erythroleukemia.

Authors:  E V Genovesi; P A Marx; E F Wheelock
Journal:  J Exp Med       Date:  1977-08-01       Impact factor: 14.307

View more
  28 in total

1.  Use of the Trypanosoma cruzi recombinant complement regulatory protein to evaluate therapeutic efficacy following treatment of chronic chagasic patients.

Authors:  Wendell S F Meira; Lúcia M C Galvão; Eliane D Gontijo; George L L Machado-Coelho; Karen A Norris; Egler Chiari
Journal:  J Clin Microbiol       Date:  2004-02       Impact factor: 5.948

2.  A DTU-dependent blood parasitism and a DTU-independent tissue parasitism during mixed infection of Trypanosoma cruzi in immunosuppressed mice.

Authors:  Helioswilton Sales-Campos; Henrique Borges Kappel; Cristiane Pontes Andrade; Tiago Pereira Lima; Mardén Estevão Mattos; Alessandra de Castilho; Dalmo Correia; Luis Eduardo Ramirez Giraldo; Eliane Lages-Silva
Journal:  Parasitol Res       Date:  2013-11-01       Impact factor: 2.289

3.  Modulation of sensitivity of blood forms of Trypanosoma cruzi to antibody-mediated, complement-dependent lysis.

Authors:  F Kierszenbaum; M A Ramirez
Journal:  Infect Immun       Date:  1990-01       Impact factor: 3.441

4.  Trypanosoma cruzi infection in rats induced early lesion of the heart noradrenergic nerve terminals by a complement-independent mechanism.

Authors:  C R Machado; D A de Oliveira; M J Magalhaes; E M Carvalho; F J Ramalho-Pinto
Journal:  J Neural Transm Gen Sect       Date:  1994

5.  Purification of a Trypanosoma cruzi membrane glycoprotein which elicits lytic antibodies.

Authors:  K A Norris; G Harth; M So
Journal:  Infect Immun       Date:  1989-08       Impact factor: 3.441

6.  Restricted IgG isotype profiles in T. cruzi infected mice and Chagas' disease patients.

Authors:  M T Scott; M Goss-Sampson
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

7.  Inefficient complement system clearance of Trypanosoma cruzi metacyclic trypomastigotes enables resistant strains to invade eukaryotic cells.

Authors:  Igor Cestari; Marcel I Ramirez
Journal:  PLoS One       Date:  2010-03-16       Impact factor: 3.240

8.  Use of a 24-kilodalton Trypanosoma cruzi recombinant protein to monitor cure of human Chagas' disease.

Authors:  G M Krautz; L M Galvão; J R Cançado; A Guevara-Espinoza; A Ouaissi; A U Krettli
Journal:  J Clin Microbiol       Date:  1995-08       Impact factor: 5.948

9.  Immunization with Trypanosoma cruzi epimastigote antigens incorporated into iscoms protects against lethal challenge in mice.

Authors:  F G Araujo; B Morein
Journal:  Infect Immun       Date:  1991-09       Impact factor: 3.441

10.  Binding of the specific ligand to Fc receptors on Trypanosoma cruzi increases the infective capacity of the parasite.

Authors:  C Rodriguez de Cuna; F Kierszenbaum; J J Wirth
Journal:  Immunology       Date:  1991-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.